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Abstract 
The role of cellular changes in the neurovascular unit is increasingly being investigated 
to understand the pathogenesis of $O]KHLPHU¶Vdisease. The aim of the current study was to 
determine the time course of recognition memory impairment in the J20 mouse model of AD, 
LQUHODWLRQWRQHXURLQIODPPDWRU\UHVSRQVHVDQGWKHSDWKRORJ\RI$ȕ 
Male hAPP-J20 and wild-type mice were assessed at 3, 6, 9, and 12 months of age. The 
spontaneous object recognition (SOR) task provided a measure of memory, with assessment of 
both a short delay (1 min) and a long delay (4 hrs). Immunohistochemistry was used to 
characterise $ȕ-deposition, and quantify astrocyte and microglial responses. 
At all ages tested J20 mice had impaired long-term, but preserved short-term, 
recognition memory. Wild-types demonstrated preserved long-term memory up to 9 months of 
age, and preserved short-term memory at all ages tested. Plaque pathology in the J20 mice was 
present from 6 months onwards, with co-localisation of reactive microglia and activated 
astrocytes. Reactive microglia and astrocyte activation in the hippocampus were significantly 
greater in the J20 mice at 9 months, compared to wild-types. 
This study contributes to our understanding of the pathological and cognitive 
mechanisms at play in AD. J20 mice showed impairment in retaining information over longer 
periods from an early age, SUHFHGLQJWKHGHSRVLWLRQRI$ȕDQGJOLDOactivation. Defining early 
physiological changes in relation to cognitive decline could provide insight into new 
therapeutic targets early in the disease process, when intervention is most likely to effectively 
slow disease progression. 
 
 
 
Keywords: 
$O]KHLPHU¶VGLVHDVHK$33-J20, recognition memory, amyloid, astrocytes, microglia 
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Introduction 
 $O]KHLPHU¶V GLVHDVH $' LV FKDUDFWHULVHG E\ D GHFOLQH LQ FRJQLWLYH VNLOOV VXFK DV
memory and visuo-spatial capabilities. Pathological characteristics of AD include beta amyloid 
$ȕSODTXHVK\SHUSKRVSKRU\ODWHGWDXIRUPLQJQHXURILEULOODU\Wangles [NFTs; 1], synapse and 
neuron loss, and neuroinflammation [2]. However, the mechanistic links between cognitive 
phenotypes and specific neuropathologies needs further definition.  
 A number of AD mouse models have been generated to recapitulate the pathological 
and behavioural features of the disease (see [3, 4, 5]). No one model yet exists that fully 
recapitulates all aspects of AD; however, each model enables specific aspects of the disease to 
be interrogated. 
 The hAPP-J20 mouse model of AD includes both the Swedish (K670N and M671L) 
and Indiana (V7171F) mutations on a C57Bl/6 x DBA2J background. This model is 
particularly useful for investigating amyloid pathology, as it features an overexpression of 
$ȕ-42, with early plaque deposition from around five months of age. Previous cognitive tests 
have revealed varying results, but generally report impairments in recognition and spatial 
memory that closely coincide with amyloid deposition in the hippocampus and cortex, though 
this is dependent on task parameters [3, 6-10]. 
The J20 mouse model develops pathological hallmarks typical of AD, such as astrocyte 
activation and reactive microglia. Astrocytes are part of the neurovascular unit and play a role 
in maintaining homeostasis [11]. When activated, astrocytes undergo morphological changes, 
such as developing shorter and thicker processes, and releasing pro-inflammatory factors [12]. 
Microglia are also reactive in AD [13, 14]; bRWKDVWURF\WHVDQGPLFURJOLDUHVSRQGWR$ȕSODTXH
formation, but more research is needed to determine whether they have a neuroprotective 
function, or contribute to the progression of neurodegeneration [15]. Microglial responses are 
complex and diverse, and may be differentially associated with AD pathology, with a decrease 
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in microglial motility reducing neuroprotection, but an increase in phagocytosis contributing 
to the progression of neurodegeneration [16]. In the J20 mouse model, increases in microglial 
reactivity and activated astrocytes relative to wild-type controls have been reported as a 
function of age [17], although reports have also found astrocytes with morphological changes 
with a decrease in number and cell complexity [6]. 
Recognition memory is the ability to recognise when something has been previously 
encountered, and is a form of declarative memory that also includes episodic memory (memory 
for a past experience in your life; [see 18-23]) which is impaired in AD. The spontaneous object 
recognition (SOR) task [24] has been successfully used to assess recognition memory in 
rodents following selective brain impairment, with further task adaptations allowing for more 
complex forms of memory involving spatial and contextual discriminations [25-28]. Lesion 
studies have revealed that for the standard SOR task, the perirhinal cortex is necessary for 
accurate recognition [29-33], but not the hippocampus or the fornix (subcortical fibre pathway 
leading to the hippocampus) [28, 30, 34]. When the delay between the sample and test phase 
is substantially long, studies have, however, reported impairments on the SOR task in rodents 
with hippocampal lesions [35, 36]. The increased delay diminishes the memory strength for 
the familiar object, making successful discrimination during the test phase more difficult [37]. 
Previous research has shown that J20 AD mice are able to perform successfully on the 
SOR task up to 15-16 months of age, with a delay between sample and test phases of up to one 
hour [38]. If the delay is increased to four hours, the J20 mice become impaired at a younger 
age of 2-3 months [9] or six to eight months [7] depending on the exact task protocol. If the 
delay is further increased to 24 hours, the J20 mice are unable to discriminate between novel 
and familiar objects from as young as four months of age [8]. Although it appears that J20 mice 
experience impairments in recognition memory both as they age, and with an increased demand 
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on memory through longer delays, it is unclear how much of this impairment can be attributed 
to age, the length of the delay, and the disease progression. 
The aim of the current study was to determine the time course of recognition memory 
impairment in the J20 mouse model of AD in relation to neuroinflammatory responses and the 
SDWKRORJ\RI$ȕWRHOXFLGDWHZKHWKHUWKHVHSDWKRORJLHVSUHFHGHFRJQLWLYHLPSDLUPHQWRURFFXU
later. Such information is likely to be informative as to what should be modulated in order to 
affect cognition in AD. 
Two SOR tasks were performed; the first involved a short delay between sample and 
test phases of one minute (short-term recognition memory), and the second involved a long 
delay of four hours (long-term recognition memory). Comparing performance on these two 
tasks enabled a characterisation of the decline of separate memory processes in normal aging 
(via performance of the wild-type controls), and in disease (via the J20 AD mice) at distinct 
time points in order to define the temporal relationship of pathological cellular changes to these 
cognitive defects. 
 
Method 
Subjects 
Male hemizygous transgenic mice (hAPP-J20) that overexpress a mutant form of the 
human amyloid precursor protein (hAPP) carrying the Swedish (K670N and M671L) and 
Indiana (V7171F) mutations were obtained from Jackson Laboratories (Bar Harbor, ME), and 
crossed with C57Bl/6J female mice to produce hAPP-J20 mice and wild-type littermate 
controls. Pups were weaned at 21 days of age and progeny ear-clipped and genotyped 
7UDQVJHQH)RUZDUG¶-GGT GAG TTT GTA AGT GAT GCC-¶7UDQVJHQH5HYHUVH¶-TCT 
TCT TCT TCC ACC TCA GC-¶). 
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An a priori power analysis yielded a suitable total sample size of 45 for obtaining 
statistically meaningful results. A total of 54 male hAPP-J20 and wild-type mice were used, 
with eight transgenic mice for each of the four time points (with the exception of the 3 month 
and 9 month groups which had seven), and six wild-type mice for each of the four time points 
(3 months, 6 months, 9 months, and 12 months of age). The higher allocation of animals in the 
transgenic groups was due to potential attrition from spontaneous death occurring before three 
months of age, likely due to seizures as the J20 model is known for abnormal neural 
hyperexcitability [39]. 
All animals were housed in groups of between two and five (based on keeping 
littermates together, regardless of genotype) in diurnal conditions (12-h light-dark cycle) with 
testing carried out during the light phase. Water was available ad libitum throughout the study. 
All animals were food deprived to 90% of the free-feeding body weight of age matched controls 
throughout testing. Mean weights were as follows: 3 month wild-type = 27g; 3 month J20 = 
24g; 6 month wild-type = 29g; 6 month J20 = 27g; 9 month wild-type = 37g; 9 month J20 = 
30g; 12 month wild-type = 39g; 12 month J20 = 31g. All experiments were performed in 
accordance with the U.K. Animals (Scientific Procedures) Act (1986) and associated 
guidelines, and have been reported in accordance with the ARRIVE (Animal Research: 
Reporting of In Vivo Experiments) guidelines. 
 
Apparatus 
Object recognition memory was tested in a square shaped arena which included an outer 
corridor surrounding the perimeter (Figure 1). The apparatus was 50cm long and 50cm wide, 
with the inner open field being 34cm long and 34cm wide. Four mechanical doors (8cm wide) 
divided the inner open field with the outer corridor, with one door in the centre of each of the 
four sides of the arena. These doors could be opened and closed remotely, and separate 
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removable corner walls divided each of the four corridors surrounding the inner open field. 
Only one door (and subsequently one corridor) was used in this study for the animals to shuttle 
between the areas during and between trials, as the corridor served purely as a holding area for 
the animal in between phases when objects were being changed. Objects were placed centrally 
in the open field, with one object on the left and one on the right, approximately 2cm or more 
away from the walls to allow the animals to fully explore the objects. 
 
Objects 
Various objects of different sizes, shape, colour, and texture were used as stimuli in the 
object recognition experiments, with identical duplicate objects used within each trial. Each 
animal did not re-encounter the same object within an object recognition experiment or on any 
subsequent object recognition test. 
 
Pretraining 
All animals were given two sessions of handling and two sessions of habituation to the 
testing room, where they remained in a holding cage with their home cage mates for a period 
of 10 minutes per session. Each group of animals housed together had their own holding cage 
so as to minimise stress from mixing smells of animals from different home cages. 
Pretraining lasted for approximately five days, and involved the completion of five 
phases aimed to habituate the animals to the environment and task procedure. Phase 1 involved 
placing the animals in the apparatus to freely explore with their cage mates for 30 minutes. For 
Phase 2, the animals were individually placed into the apparatus for 20 minutes to freely 
explore. This was repeated for Phase 3 for 10 minutes. Phase 4 was aimed at training the 
animals to shuttle between the outer corridor and the open arena. Three 10 minute sessions 
were carried out and involved placing single MLab rodent pellets (45mg, TestDiet; Richmond, 
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Indiana, USA) in both the centre of the open field, and behind the door leading to the outer 
corridor. The food was replenished after the completion of each shuttle. Phase 5 introduced 
objects into the open field, whereby individually the animals shuttled into the open field from 
the outer corridor and were exposed for three minutes to two identical objects, each baited with 
a single food pellet. The door leading to the outer corridor was then opened for the animals to 
shuttle through to the outer corridor, which contained a single food pellet. Once the objects had 
been changed, the door opened for the animals to shuttle back into the open field containing a 
duplicate copy of the object from the sample phase and a novel object, again each baited with 
a single food pellet. After three minutes, the animals then shuttled back in to the outer corridor 
when the door was opened. This procedure was carried out for a total of three different pairs 
of objects (not re-used in the experiment proper). 
 
Test protocol for short-term object recognition memory 
Each mouse was given a single testing session of 10 trials (Figure 1). At the start of 
each session, the animal was placed in the outer corridor (only one of the four were used, and 
this was the same for all mice), with the door opening immediately so they could move through 
to the open field. Each animal spent three minutes in the open field exploring the objects during 
the sample phase. The door to the outer corridor was then opened, and the animal shuttled 
through to the outer corridor to obtain a single food pellet. After one minute the door opened 
to allow the animal back into the open field for the test phase which contained a duplicate copy 
of the now familiar object from the sample phase and a novel object (trial 1). Following three 
minutes, the door opened and the animal shuttled through to the outer corridor. After a period 
of one minute, the door was then opened for trial 2 allowing the animal back into the open field 
for the sample phase of trial 2, and so on. This procedure continued for a total of 10 trials. All 
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objects were baited with a food pellet to encourage exploration of objects without differentially 
rewarding choices. 
The location of the novel object was counterbalanced to minimise bias for left or right 
exploration within each testing session and also between animals. Objects were also 
counterbalanced between animals for which was novel and which was familiar, to minimise 
bias for a particularly salient object. A trial was ended if the animal failed to shuttle to the next 
area of the apparatus after a period of three minutes, ceasing the testing session. 
 
Test protocol for long-term object recognition memory 
The protocol for long-term object recognition memory followed the week after testing 
for the short-term object recognition memory had been completed. The test protocol for this 
task was identical to that of the short-term object recognition memory task, however the delay 
between sample and test phases on each trial was extended to four hours, in which the animal 
was removed from the apparatus and placed back in their home cage.  Subsequently, it was 
only possible to carry out one trial a day for each animal, of which four trials were carried out 
in total on consecutive days.  
 
Behavioural analysis 
Object exploration was defined as when the nose of the animal was <1cm from the 
object, RULIWKHREMHFWZDVWRXFKHGZLWKWKHDQLPDO¶VQRVH(directed within 45q of the object) 
or paws. Sitting or climbing on the object were actions not counted as exploration. Duration of 
exploration was measured off-line using a computerised stop-watch mechanism whilst 
exploration was observed by the experimenter on a recording. Discrimination was measured 
using D2 scores [19] which are calculated using the difference in exploration time (exploration 
time for the novel object minus the exploration time for the familiar object) divided by the total 
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exploration time. A D2 score was calculated for each individual trial then averaged to give a 
mean D2 score for each animal, which were then used in the data analysis. The D2 index ranged 
from -1 to +1, with -1 representing total exploration of the familiar object, +1 representing total 
exploration of the novel object, and 0 being indicative of no object preference.  
 
Immunohistochemistry 
 The animals were humanely euthanased with i.p. injections of sodium pentobarbital 
(100mg/kg, Euthatal, Merial Animal Health Ltd). They were then transcardially perfused with 
0.9% phosphate buffered saline (warmed to 37oC) with the addition of heparin (0.1ml/500ml). 
Brains were removed from the skull, dissected to separate the two hemispheres, with the right 
hemisphere subdissected coronally into four parts (cerebellum, frontal lobe, and the remaining 
tissue cut in half) and then snap frozen in liquid nitrogen for storage at -80oC. The left 
hemisphere was post fixed in 4% paraformaldehyde (0.1M, pH 7.4) and subdissected into four 
regions, as described, after 24 hours. Following fixation, the tissue was embedded in paraffin 
wax. 
Serial sections (5µm) were cut from the paraffin-embedded tissue. 
Immunohistochemistry was carried out using a standard avidin-biotin complex (ABC) method. 
Sections were first deparaffinised, rehydrated to water, followed by quenching of endogenous 
peroxidase activity through placing the sections in 0.3% H2O2/methanol for a total of 20 
minutes at room temperature (RT).  
Sections underwent antigen retrieval based on prior antibody optimisation; single and 
dual immunolabelling for Iba1 (Ionized calcium binding adaptor molecule 1) underwent  
microwave antigen retrieval for 10 minutes (pH9), and single and dual immunolabelling for 
GFAP (glial fibrillary acidic protein) underwent pressure cooker antigen retrieval for 20psi at 
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120oC for 45s (pH6.5). All immunolabelling for $ȕLQFOXGHGadditional pre-treatment of the 
sections in 70% formic acid for 10min at RT. 
Following antigen retrieval, sections were incubated in 1.5% blocking solution for 30 
minutes at RT, before further incubation in the primary antibody (anti-Iba1 ± 1:200, Abcam, 
UK; biotinylated anti-$ȕ± 1:500, BioLegend, USA; anti-GFAP ± 1:500, Dako, USA) made in 
blocking solution for 60 minutes at RT. Antibody binding was visualised using the standard 
horseradish peroxidase avidin-biotin complex method (Vectastain Elite kit, Vector 
Laboratories, UK), with 3,3-diaminobenzidinetetrahydrochloride (DAB) as the chromogen 
(Vector Laboratories, UK; brown). Sections were further counterstained with haematoxylin 
(Cell Path, UK), dehydrated, and cleared in xylene before mounting in DPX (Leica, UK). 
Negative controls, with the omission of the primary antibody and isotype controls, were 
included with every run. 
For dual-staining experiments, GFAP or Iba1 expression was visualised as described 
above. Sections were then incubated with the avidin-biotin blocking kit (Vector Laboratories, 
UK), according to the manufacturHU¶VLQVWUXFWLRQV The tissue was incubated overnight at 4oC 
with anti-$ȕand visualised with the alkaline-phosphatase-conjugated avidin-biotin complex 
and alkaline phosphatase substrate 1 (Vector Laboratories, UK, red). Sections were 
counterstained with haematoxylin.  
 
Regions of interest 
Quantification of GFAP and Iba1 immunoreactivity was carried out using a Nikon 
Eclipse Ni-U microscope and Nikon DS-Ri1 camera with NIS-Elements BR 4.20.01 64-bit 
microscope imaging software (Nikon, UK), capturing bright-field images in subregions of the 
hippocampus and cortex, using a 20x objective. Regions of interest were identified with 
reference to the mouse brain anatomy atlas by Paxinos and Franklin [40]. For the perirhinal 
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and somatosensory cortices, two adjacent belt transects from the outer cortex through to the 
white matter border were taken for each animal at 20x magnification. Each belt transect 
contained up to four images, and the area coordinates for the captured images were taken 
between AP -1.07 to -2.45 relative to bregma for the somatosensory region, and between AP -
1.67 to -2.53 relative to bregma for the perirhinal cortex. Subfields of the hippocampus (CA1, 
CA3, and dentate gyrus) were imaged between AP -1.67 to -3.51 relative to bregma. All slides 
were imaged blind in a random order. 
 
Neuropathological quantification and statistical analysis 
 The images were thresholded and the GFAP or Iba1 immunoreactive area of the field 
determined per total area examined, using the Analysis ^D software. The average percentage 
area of immunopositive staining was used for statistical analysis for both antibodies, for wild-
type and J20 mice, and statistically analysed using a two-way ANOVA with age (3, 6, 9, and 
12 months) and genotype (J20 and wild-type) as between subject factors. All images were 
analysed blind in a randomised order.  
 
Results 
Behavioural results: J20 mice show short-term recognition memory up to 12 months of age 
Five animals died before reaching the age for behavioural testing; one from the three 
month J20 group, one from the six month J20 group, one from the nine month J20 group, and 
two from the 12 month J20 group. 
To determine whether the animals performed above chance, a one-sample t-test (two-
tailed) was used to compare the mean D2 scores against zero for each genotype group at each 
of the four ages. Both J20 and wild-type mice could successfully discriminate between novel 
and familiar objects at all ages tested, though J20 mice did not perform quite as well as wild-
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type mice (see Figure 2a legend). For the mean D2 scores, there was a significant main effect 
of genotype (F(1,41) = 6.736, p = 0.013), with the J20 mice overall obtaining lower mean D2 
scores compared to wild-types (t(47) = 2.639, p = 0.011), but no significant main effect of age 
(F(3,41) = 1.728, p = 0.176), or interaction (F(3,41) = 0.329, p = 0.804) was found.   
For the total amount of time spent exploring the objects in the test phase, independent-
samples t-tests between J20 and wild-type mice at each time point showed no significant 
differences in total exploration time (see Figure 2c legend). However, there was overall a 
significant main effect of genotype (F(1,41) = 6.329, P = 0.016), with the J20 mice spending 
significantly less time exploring overall in the test phase compared to wild-types (t(33.265) = 
2.263, p = 0.030), and age (F(3,41) = 3.151, p = 0.035), with a variable decline in exploration 
with age. There was no significant interaction between genotype and age (F(3,41) = 2.392, p = 
0.082).  
 
J20 mice are significantly impaired at long-term recognition memory 
The wild-type mice were able to successfully discriminate between the novel and 
familiar stimuli up to nine months of age, but failed recognition at 12 months of age, and the 
J20 mice were unable to discriminate at all ages tested (see Figure 2b legend). There was a 
trend towards a significant main effect of genotype on the mean D2 score (F(1, 41) = 3.996, p 
= 0.052) with the J20 mice overall obtaining lower mean D2 scores compared to wild-types 
(t(47) = 2.098, p = 0.041), but no main effect of age (F(3, 41) = 0.197, p = 0.898) or significant 
interaction (F(3, 41) = 0.537, p = 0.659) was found. 
For the total amount of time spent exploring the objects in the test phase, independent-
samples t-tests between J20 and wild-type mice at each time point showed significantly lower 
total exploration times for J20 mice at 3, 6, and 9 months of age (see Figure 2d legend). There 
was overall a significant main effect of genotype (F(1,41) = 20.781, p = <0.001), with the J20 
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mice spending significantly less time exploring overall in the test phase compared to wild-types 
(t(38.783) = 4.348, p = <0.001), but no significant main effect of age (F(3,41) = 2.371, p = 
0.084), or interaction (F(3,41) = 1.034, p = 0.387) was found.  
 
Neuropathological results: Astrogliosisis associated with age and not genotype in the 
hippocampus 
Two animals died after behavioural testing before they could be perfused; one from the 
three month J20 group, and one from the six month J20 group. In addition, the quality of tissue 
for some regions of interest was not suitable for image analysis, so the group numbers may 
vary throughout the immunohistochemistry data analysis. 
GFAP specifically immunolabelled astrocyte cell bodies and proximal processes in all 
cases. Although there was no significant difference overall between J20 and wild-type mice, 
there was a significant difference between these groups at 9 months of age in the hippocampus 
as a whole (Figure 3a), with astrocytes in J20 mice exhibited a hypertrophied appearance, 
indicative of astrogliosis (Figure 4a). Negative controls did not show any immunoreactivity. 
GFAP expression was quantified in the subfields of the hippocampus (CA1, CA3, and 
dentate gyrus [DG]). GFAP expression significantly varied with age in the CA1 (F(3,26) = 
12.117, p = <0.001), CA3 (F(3,28) = 3.091, p = 0.043), and the DG subregions (F(3,30) = 
5.633, p = 0.003). Pairwise comparisons revealed significant differences in the immunoreactive 
profile of GFAP between ages 3 and 6 months (CA1: p = 0.035), 3 and 9 months (CA1: p = 
<0.001), 6 and 12 months (CA1: p = 0.018), and 9 and 12 months (CA1: p = <0.001; CA3: p 
= 0.035; DG: p = 0.002). There was no significant association with genotype, and no significant 
interaction between age and genotype in any subregion (all p = >0.179). 
Taking the hippocampal region as a whole, combining the data from the subregions, 
GFAP expression was significantly associated with age (F(3,31) = 8.102, p = <0.001), but there 
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was no significant association with genotype, and no significant interaction between age and 
genotype (both p = >0.311). Pairwise comparisons revealed significant differences in the 
immunoreactive profile of GFAP between 3 and 9 months (p = 0.013), and 9 and 12 months (p 
= <0.001). Irrespective of genotype, levels of GFAP expression in the hippocampus decreased 
with age until around 9 months, and then increased again when measured at 12 months of age. 
Independent-samples t-tests between J20 and wild-type mice at each time point showed 
J20 mice had significantly greater GFAP expression in the hippocampus at 9 months of age, 
but at no other time point (see Figure 3a legend). 
 
Microgliosis associated with age and not genotype in the hippocampus 
Iba1 specifically immunolabelled microglial cell bodies and processes in all cases. 
Although there was no significant difference overall between J20 and wild-type mice, there 
was a significant difference between these groups at 9 months of age in the hippocampus 
(Figure 3b), with microglia in J20 mice displayed a hypertrophic profile with larger cell bodies, 
indicating microglial reactivity (Figure 4c). Negative controls did not show any 
immunoreactivity. 
Iba1 expression was quantified in the subfields of the hippocampus (CA1, CA3, and 
DG). Iba1 expression significantly varied with age in both the CA1 (F(3,27) = 4.392, p = 0.012) 
and DG subregion (F(3,30) = 3.414, p = 0.030). Pairwise comparisons revealed significant 
differences in the immunoreactive profile of Iba1 between ages 3 and 6 months (CA1: p = 
0.013), and 6 and 9 months (CA1: p = 0.049), and a trend towards significant difference 
between ages 3 and 12 months (DG: p = 0.052). No significant association of Iba1 expression 
with age was found in the CA3 subregion (F(3,28) = 1.073, p = 0.377). There was no significant 
association with genotype, and no significant interaction between age and genotype in any 
subregion (all p = >0.170). 
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Taking the hippocampal region as a whole, combining data from the subregions, Iba1 
expression was significantly associated with age (F(3,31) = 3.584, p =0.025), but no significant 
association with genotype and no significant interaction between age and genotype was found 
(both p = >0.478). Pairwise comparisons revealed a significant difference in the 
immunoreactive profile of Iba1 between 3 and 6 months (p = 0.045). Irrespective of genotype, 
levels of Iba1 expression in the hippocampus increased from 3 to 6 months of age, before 
decreasing at 9 months, and then increasing again at 12 months of age. 
Independent-samples t-tests between J20 and wild-type mice at each time point showed 
J20 mice had significantly greater Iba1 expression in the hippocampus at 9 months of age, but 
at no other time point (see Figure 3b legend). 
 
No age or genotype associated changes in GFAP or Iba1expression in the cortex 
 GFAP and Iba1 expression was quantified throughout the perirhinal and somatosensory 
cortex but revealed no significant association with either age or genotype, either when the 
subregions were analysed separately or when taken together as a whole (all p = >0.263). 
 
$ȕSODTXHGHSRVLWLRQSUHVHQWLQ-PLFH 
 $ȕ plaques, predominantly located in the hippocampal and cortical regions, were a 
prominent feature of the J20 mice, but not wild-type control mice (Figure 5). Negative controls 
did not show any immunoreactivity. $WDQGPRQWKVRIDJHGLIIXVHVWDLQLQJRIVROXEOH$ȕ
was localised primarily in the white matter border between the hippocampal and cortical 
UHJLRQV $W  PRQWKV RI DJH FRPSDFW $ȕ SODTXHV ZHUH GHSRVLWHG SUHGRPLQDQWO\ LQ WKH
hippocampus, with some beginning to develop in the cortex. By 12 months of age, compact 
plaques were located across the hippocampus (all subregions) and sparsely across the 
somatosensory cortex, but little deposition was found in the perirhinal cortex. 
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 Dual-ODEHOOLQJRIWKH$ȕSODTXHVDQG either astrocytes (GFAP) or microglia (Iba1) in 
the J20 mice displayed co-localisation from 9 months of age (Figures 6a and 6b). Gliotic 
astrocytes primarily localised with compact plaques, but also infrequently with diffuse plaques. 
These reactive astrocytes completely surrounded the plaques, with extension of their processes 
into these deposits. Reactive microglia were intimately associated with both diffuse and 
compact plaques, with even relatively small depositions surrounded by microglia with large 
cell bodies and retracted processes. 
 
Discussion 
The aim of this study was to determine the time course of recognition memory 
LPSDLUPHQWLQWKH-PRXVHPRGHORI$'LQUHODWLRQWR$ȕSDWKRORJ\DQGQHXURLQIODPPDWRU\
responses. To our knowledge, this is the first characterisation of $ȕDQGQHXURLQIODPPDWRU\
pathology in J20 mice that varies with age, and a dissociation in short- and long-term 
recognition memory ability that was not observed in wild-type mice.  
On a task of short-term recognition memory, both J20 and wild-type mice at all ages 
tested were able to successfully discriminate between novel and familiar objects. On a task of 
long-term recognition, however, J20 mice were impaired at all ages tested and wild-type mice 
were only able to show significant long-term recognition up to 9 months of age. Previous 
studies have reported that J20 mice are impaired from 4 months of age in a recognition memory 
task with a 24 hour delay [8], but when the delay is shortened to 4 hours, J20 mice show 
successful recognition memory up to 6-8 months of age [7]. Harris et al. [9] have reported 
impairment from 2-3 months. It is clear, therefore, that the length of the delay between the 
sample and test phase can influence the memory load demand, and the age of the AD mouse 
(or the progression of the disease), also contributes to the degree to which this demand impacts 
upon recognition memory performance. 
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It is important to highlight key methodological differences between the short and long 
delay recognition memory tasks when comparing performance in the current study. Both tasks 
were completed within the same apparatus, but the short-term recognition memory task 
comprised of a 3 minute sample phase and a 3 minute test phase, with trials completed 
consecutively in a multi-trial paradigm. This paradigm typically results in less variability in the 
data as animals do not need to be handled repetitively before and after each phase of a trial 
which can induce anxiety in mice, allowing for multiple trials to therefore be carried out [41]. 
As it is not possible to perform a long-term recognition memory task with a similar paradigm, 
the standard version of this task was used with a 10 minute sample phase, and a 5 minute test 
phase following the 4 hour delay. The longer sample and test phases closely reflected the task 
used by Harris et al. [9]. Therefore only anecdotal, rather than statistical, comparisons have 
been made between performances on the two tasks, with a focus on comparing age and 
genotype differences statistically within each task. The results from these tasks when 
considered separately, therefore, reflect previous findings from Karl et al. [38] with successful 
recognition in the short-term SOR task up to 12 months of age, and impairment in long-term 
SOR from 3 months of age [9]. A recent study, however, has reported impaired recognition 
memory in J20 mice from six months of age, with a short one minute delay between sample 
and test phases [42]. This contrasts with the results from the current short term SOR task, which 
J20 mice could perform successfully up to 12 months of age. The difference in results may, in 
some part, be accountable by task protocol differences whereby the continual trials design in 
the current study allowed for more trials to be carried out per animal without being handled 
before and after trial phases. The memory impairment shown by J20 mice in the study by 
Criscuolo et al. [42] may reflect an inability to perform the task due to confounding factors, 
such as anxiety, rather than a clear memory deficit. 
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The current study showed that J20 mice had significantly lower exploration times 
compared to wild-type mice in the long-term recognition memory task. As these animals did 
not experience mobility impairments that would have restricted them from exploring the 
objects, the memory impairment observed in the J20 mice in the long delay task is unlikely to 
be a direct result of these lower exploration times, as these animals should still be able to 
discriminate between novel and familiar stimuli if this ability is not impaired. 
Immunohistochemistry revealed no quantifiable differences in GFAP and Iba1 
expression in the cortical subregions between J20 and wild-type mice, at all ages. Taking the 
hippocampal region as a whole, GFAP and Iba1 expression significantly varied with age, with 
GFAP expression decreasing until 9 months of age and then increasing; and Iba1 expression 
increasing until 6 months of age, decreasing at 9 months, and then increasing again at 12 
months. There were no overall significant differences between J20 and wild-type mice; 
however, GFAP and Iba1 immunoreactivity was significantly higher in J20 mice than in wild-
type controls at 9 months of age, likely due to fluctuations found in the wild-type mice across 
the age groups. $ȕ SODTXHV ZHUH GHSRVLWHG IURP  PRQWKV RI DJH LQ WKH - PLFH
predominantly in the hippocampus, consistent with previous pathological descriptions of this 
model [43]. There were no significant neuropathological changes in the perirhinal cortex 
region, or the cortical region more widely when the results were pooled together. In addition, 
plaque deposition was relatively sparse in this region. The lack of recognition memory 
impairment observed in the J20 mice in the short delay task is therefore not surprising, 
considering this type of memory has been shown to be perirhinal cortex dependant [29-33]. 
There are clear morphological changes showing astrocyte activation and reactive 
microglia in the J20 mice (Figure 4a and 4c), however, there were no significant overall 
differences between J20 and wild-type mice in terms of GFAP and Iba1 expression in the 
hippocampus. There was a significant genotype difference at 9 months of age for both of these 
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glial responses, but this is likely due to fluctuant age-dependent differences found in wild-type 
mice. For GFAP expression, the difference could be attributed to a significant decline at 9 
months of age, and for Iba1 expression, the difference could be attributed to a significant 
increase at 6 months of age, which then reduces again at 9 months in wild-type mice. There is 
a lack of consistency amongst previous studies on glial pathology in aging, with some reporting 
astrocyte or microglial hyperplasia and hypertrophy [44-47] or, in contrast, atrophy [48]. It is 
possible that age-related variations in glial response may also be region specific, particularly 
in terms of morphological changes [49]. In the current study, such age-related changes are not 
clear across the age groups in the J20 mice, perhaps due to a more chronic state of astrocyte 
activation and microglial reactivity that ultimately results in this case in a significant difference 
in GFAP and Iba1 expression between wild-type and J20 mice at 9 months of age, as the wild-
type expression values fluctuate.  
The current study did not clearly identify a causal link between the neuropathological 
and cognitive changes measured, but does provide a characterisation of these changes and when 
they occur. As previously mentioned, J20 mice up to at least 12 months of age have preserved 
short-term recognition memory function which is perirhinal cortex dependent [29-33]. 
Alongside the lack of pathological changes in the cortex across all ages measured, these 
findings suggest that J20 mice have preserved cortical function. Recent data from our lab 
supports this assumption, as we found that 9-12 month old J20 mice have preserved 
haemodynamic and neural responses measured in the somatosensory cortex when compared to 
wild-type mice [50], contrary to previous studies [51-54]. If J20 mice have preserved cortical 
function overall, this would explain the lack of short-term memory impairment in J20 mice. 
From 3 months of age, J20 mice have impaired recognition memory when there is a 
long delay between sample and test phases, which studies have previously shown to be 
hippocampal-dependent [35-36]. This impairment cannot be attributed to significant changes 
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in glial pathology as these were not found at 3 months of age. There was, however, clear diffuse 
VWDLQLQJ RI VROXEOH $ȕ SULPDULO\ RQ WKH ZKLWH PDWWHU ERUGHU EHWZHHQ WKH Kippocampal and 
cortical regions that could, alongside a related neuropathological change not measured in this 
current study, be correlated with the impairment in long-term recognition memory in J20 mice. 
)RULQVWDQFHROLJRPHULFOHYHOVRI$ȕZHUHQRWDVVHVVHGLQWKHFXUUHQWVWXG\EXWWKH\GRSOD\
a key role in the pathogenesis of AD with studies showing that cognitive dysfunction coincides 
with the presence of significaQW$ȕROLJRPHUVin the Tg2576 AD mouse model [55]. In addition, 
reducinJ OHYHOV RI $ȕ ROLJRPHUV UHVXOWHG in improved cognition in transgenic mice 
overexpressing APP [56], and in the 5xFAD and APP/PS1 AD mouse models [57, 58]. It is 
possible that the long-term recognition memory impairment observed in the J20 mice from 3 
months of age could be linked to early oligomer formation. Further work should also 
characterise synaptic function in the hippocampus which has been reported be impaired in APP 
mice prior to $ȕSODTXHGHSRVLWLRQ>59-62]. 
Astrogliosis manifests in upregulation of GFAP expression, with hypertrophic cell 
bodies and processes and astrocyte proliferation [63]. Although astrocyte hypertrophy is a 
common feature of AD, it may also be important to consider astrocyte atrophy and the 
associated functional changes, as this has been reported in the early stages of the disease in 
transgenics, such as the 3xTg-AD model [64-66]. 7KLV PRGHO H[KLELWV ERWK $ȕ DQG 1)7V
allowing assessment of astrocyte response to both pathological features, and therefore may 
recapitulate aspects of AD more effectively than the J20 mouse model which only 
RYHUH[SUHVVHV OHYHOV RI $ȕ $ UHFHQW VWXG\ E\ *RRGDOO HW DO [67] reported an overall age-
associated increase in astrocyte activation in C57 mice, but in the current study this pattern was 
not observed and the lack of genotype- or age-associated proliferation may be partially 
attributable to astrocyte atrophy. Moreover, astrocyte atrophy can lead to synapse loss and 
reduced neuronal metabolic support, which can ultimately result in early cognitive deficits [66]. 
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As previously mentioned, it would therefore be useful to characterise hippocampal synaptic 
function particularly to see if this is in part accountable for the long-term recognition memory 
impairment observed in the J20 mice from 3 months of age. 
7KHFXUUHQWVWXG\VKRZHGWKDW$ȕFRPSDFWSODTXHVZHUHFR-localised and infiltrated by 
activated astrocytes and reactive microglia, which has been previously reported [68-70], and 
Simpson et al. [71] specifically reported a trend to increased GFAP expression with neuritic, 
rather than diffuse, plaques. Research is ongoing to elucidate whether the activated glia act as 
D QHXURSURWHFWLYH EDUULHU WKURXJK GHJUDGLQJ DQG FOHDULQJ $ȕ [63, 72], or whether they 
contribute to the degeneration progression through the release of inflammatory mediators [73]. 
Research suggests that glial activation is a defensive response against injury, disease, or 
infection, but excessive activation, or activation sustained over longer periods, may act as a 
contributing factor to degeneration [74-76]. A recent study by Mathur et al. [77] proposed that 
astrocytes not only form a protective barrier around amyloid plaques, but astrogliosis 
negatively related to measures of cognitive impairment, showing a potential neuroprotective 
role. 
It is important to acknowledge that using a single sex in this study may present as a 
potential limiting factor. Previous research varies in the extent to which sex differences may 
have an effect on AD phenotypes in mice, particularly in terms of whether certain hormones 
provide a protective or deleterious effect [3]. Due to the between- and within-subject design of 
the current study, we opted to exclusively use male mice to minimise variability, but recognise 
the need for more research into sex differences in disease models and the effect of hormones, 
particularly in preclinical studies for drug development. 
In summary, the current study showed J20 mice were impaired in retaining information 
over longer periods from an early age, but were able to retain information over short periods 
of time, up to at least 12 months of age. The long-term memory impairment did not appear to 
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be linked to either the markers for neuroinflammatory responses, as no overall genotype only 
significant overall age-UHODWHGIOXFWXDWLRQVZHUHIRXQGQRU$ȕSDWKRORJ\ZKLFKZDVSUHVHQW
later. The study was limited in terms of the neuropathological markers that were observed, but 
nevertheless demonstrates that $ȕ deposition and cellular neuroinflammatory responses do not 
precede cognitive impairment. As a clear dissociation in performance on recognition memory 
was found for the J20 mice, further work to elucidate the pathology of synaptic function would 
be useful to establish whether this or oligomeric changes may be related to the observed 
recognition memory deficits DQG WKH DFFXPXODWLRQ RI $ȕ. Work should also explore more 
deeply how age- and disease-related neuropathological changes intersect. 
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Fig. 1. 
An illustration of the short-term spontaneous object recognition (SOR) memory test procedure 
showing sample and test phases for two trials with a one minute delay between phases. Each 
mouse was given a single testing session of 10 trials from which mean D2 scores were derived. 
For the long-term SOR task with a four hour delay between sample and test phases, a standard 
one-trial a day version of the task was used with the sample phase occurring in the morning, 
and the test phase in the afternoon (always at the same time). Multiple trials were carried out 
on consecutive days and mean D2 scores derived from these raw scores.  
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Fig. 2. 
SOR memory tasks. Mean D2 scores from the SOR task with a short delay (a). All the 
groups significantly explored the novel stimuli more than the familiar stimuli (WT3m: t(5) = 
7.225, p = 0.001; WT6m: t(5) = 12.134, p = <0.001; WT9m: t(5) = 3.873, p = 0.012; WT12m: 
t(5) = 5.501, p = 0.003; J20-3m: t(5) = 5.319, p = 0.003; J20-6m: t(6) = 4.205, p = 0.006; J20-
9m: t(5) = 3.554, p = 0.016; J20-12m: t(5) = 3.554, p = 0.016); Mean D2 scores from the SOR 
task with a long delay (b). The wild-type mice were able to successfully discriminate between 
the novel and familiar stimuli up to nine months of age, but failed recognition at 12 months of 
age (WT3m: t(5) = 3.986, p = 0.010; WT6m: t(5) = 2.797, p = 0.038; WT9m: t(5) = 2.720, p = 
0.042; WT12m: t(5) = 1.168, p = 0.295). The J20 mice were unable to discriminate at all the 
ages tested (all p >0.1). Independent samples t-tests for mean D2 scores between J20 and wild-
type mice at each age for both tasks were all non-significant (all p = >0.05). Mean total 
exploration times from the SOR task with a short delay (c). Independent samples t-tests for 
mean total exploration times between J20 and wild-type mice at each age were all non-
significant (all p = >0.05). Mean total exploration times from the SOR task with a long 
delay (d). Wild-type mice had significantly greater exploration times at 3, 6, and 9 months of 
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age (WT3m: t(10) = 2.887, p = 0.016; WT6m: t(11) = 2.435, p = 0.033; WT9m: t(5.303) = 
4.271, p = 0.007), but not at 12 months of age (t(10) = 0.916, p = 0.381). Vertical bars show 
the standard error of the mean. (כ) p < 0.05; (ככ) p < 0.01; (כככ) p < 0.001. 
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Fig. 3. 
Pooled mean % immunolabelled area. GFAP in the hippocampus (a). J20 mice had 
significantly greater GFAP expression in the hippocampus at 9 months of age (t(6) = 2.822, p 
= 0.030), but at no other time point (all p = >0.700); Iba1 in the hippocampus (b). J20 mice 
had significantly greater Iba1 expression in the hippocampus at 9 months of age (t(6) = 3.169, 
p = 0.019), but at no other time point (all p = >0.256); GFAP in the cortex with no significant 
association with either age or genotype (c); Iba1 in the cortex with no significant 
association with either age or genotype (d). Vertical bars show the standard error of the mean. 
(כ) p < 0.05. 
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Fig. 4. 
GFAP+ astrocytes and Iba1+ microglia in the hippocampal subregion CA1 of 9 month old 
hAPP-J20 and wild-type mice. At 9 months of age, notable morphological differences were 
observed between J20 and wild-type mice. Right-hand side panels show high magnification 
enlargements of the outlined boxes from the left-hand side panels. Astrocytes with a prominent 
b. WT: GFAP 
c. J20: Iba1 
d. WT: Iba1 
a. J20: GFAP 
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hypertrophied appearance were a feature of J20 mice (a), compared to (b) wild-type mice.  
Similarly, at 9 months of age (c) microglia in J20 mice displayed a more reactive profile with 
enlarged cell bodies, compared to (d) wild-type mice. Scale bar represents 100µm for low 
magnification images and 25µm for high magnification images. Images are contrast enhanced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
  
 
 
 
  
  
 
Fig. 5. 
$ȕSODTXHVWDLQLQJ in the hippocampus of hAPP-J20 and wild-type mice. $ȕSODTXHVwere 
predominantly located in the hippocampal and cortical regions in the J20, but not wild-type 
PLFH$WDQGPRQWKVRIDJHGLIIXVHVWDLQLQJRIVROXEOH$ȕZDVIRXQGLQWKH-PLFH
ZKLFK SURJUHVVHG WR FRPSDFW $ȕ SODTXHV IURP  PRQWKV RI DJH SUHGRPLQDntly in the 
J20: 3 months 
J20: 6 months 
J20: 9 months 
J20: 12 months 
WT: 3 months 
WT: 6 months 
WT: 9 months 
WT: 12 months 
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hippocampus, but also in cortical areas. Scale bar represents 200µm. Images are contrast 
enhanced. 
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Fig. 6. 
Glial activation in relation to $ȕSODTXHV LQ WKHKLSSRFDPSXVRIDPRQWKROGK$33-J20 
mouse. (a) Reactive microglia (brown) with prominent cell bodies were intimately associated 
ZLWK $ȕ plaques (red). (b) Reactive astrocytes (brown) were in direct contact with and 
completely surrounded the plaques (red), with extension of their processes into these deposits. 
Scale bar represents 25µm. Images are contrast enhanced. 
 
 
 
 
 
 
 
 
D$ȕ	,ED b. $ȕ	*)$3 
